Cancer Drug Discovery Using Fragment-Based Methods
Time: 9:45 am
day: Conf Day 1
Details:
- Inhibiting KRAS, MYC, and the WNT pathway Tim Foley Lab Head, DNA-Encoded Library Selection & Pharmacology Pfizer
- Drugging highly validated cancer targets that are challenging to drug
- Using fragment-based methods and structure-based design
